These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3663273)

  • 21. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bioavailability of high-dose metoclopramide.
    Taylor WB; Bateman DN
    Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
    Graffner C; Lagerström PO; Lundborg P; Rönn O
    Br J Clin Pharmacol; 1979 Nov; 8(5):469-74. PubMed ID: 508553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results.
    Steudel HC; Volkenandt M; Steudel AT
    Z Kardiol; 1983; 72 Suppl 3():24-8. PubMed ID: 6666228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacokinetic study on midazolam in compensated liver cirrhosis.
    Rinetti M; Ascalone V; Colombi Zinelli L; Cisternino M
    Int J Clin Pharmacol Res; 1985; 5(6):405-11. PubMed ID: 2936689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form].
    Blanc M; Cales P; Grasset D; Ravaud A; Meskens C; Cotonat J; Pascal JP
    Therapie; 1987; 42(2):187-91. PubMed ID: 3616995
    [No Abstract]   [Full Text] [Related]  

  • 31. Liquid chromatographic analysis of metoclopramide with fluorescence detection in cirrhotic patients.
    Albani F; Riva R; Contin M; Baruzzi A
    Biomed Chromatogr; 1987; 2(3):135-6. PubMed ID: 3507219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.
    Somogyi A; Albrecht M; Kliems G; Schäfer K; Eichelbaum M
    Br J Clin Pharmacol; 1981 Jul; 12(1):51-60. PubMed ID: 7248141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.
    Albani F; Tamè MR; De Palma R; Bernardi M
    Eur J Clin Pharmacol; 1991; 40(4):423-5. PubMed ID: 2050180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of lidocaine after intravenous and oral administration in patients with liver cirrhosis].
    Fuchshofen M; Zilly W; Epping J; Richter E
    Verh Dtsch Ges Inn Med; 1978; (84):1110-2. PubMed ID: 741898
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.
    Bateman DN; Kahn C; Mashiter K; Davies DS
    Br J Clin Pharmacol; 1978 Nov; 6(5):401-7. PubMed ID: 728283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced oral bioavailability of meptazinol in cirrhosis.
    Birnie GG; Thompson GG; Murray T; Watkinson G; Brodie MJ
    Gut; 1987 Mar; 28(3):248-54. PubMed ID: 3570028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of metoclopramide.
    Bateman DN
    Clin Pharmacokinet; 1983; 8(6):523-9. PubMed ID: 6360466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of the individual constituents of an aspirin-metoclopramide combination ('Migravess').
    Manniche PM; Dinneen LC; Langemark M
    Curr Med Res Opin; 1984; 9(3):153-6. PubMed ID: 6499509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of laxatives and metoclopramide on plasma quinidine concentration during prolonged administration in patients with heart rhythm disorders].
    Guckenbiehl W; Gilfrich HJ; Just H
    Med Welt; 1976 Jun; 27(26):1273-6. PubMed ID: 933817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.